Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway

Astragaloside IV is a biologically active substance derived from the traditional Chinese medicine Astragalus mambranaceus Bunge, and has antioxidant, anti-inflammatory, and anti-apoptotic properties. In this study, we aimed to investigate the effects of astragaloside IV on Klebsiella pneumonia rats...

Full description

Bibliographic Details
Main Authors: Lei Li, Jie Guan, Rongjun Lin, Fang Wang, Hui Ma, Chenggang Mao, Xingqing Guo, Zhenghai Qu, Renzheng Guan
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2023-07-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2023000100646&tlng=en
_version_ 1797773110175334400
author Lei Li
Jie Guan
Rongjun Lin
Fang Wang
Hui Ma
Chenggang Mao
Xingqing Guo
Zhenghai Qu
Renzheng Guan
author_facet Lei Li
Jie Guan
Rongjun Lin
Fang Wang
Hui Ma
Chenggang Mao
Xingqing Guo
Zhenghai Qu
Renzheng Guan
author_sort Lei Li
collection DOAJ
description Astragaloside IV is a biologically active substance derived from the traditional Chinese medicine Astragalus mambranaceus Bunge, and has antioxidant, anti-inflammatory, and anti-apoptotic properties. In this study, we aimed to investigate the effects of astragaloside IV on Klebsiella pneumonia rats and the underlying mechanisms. Klebsiella pneumoniae (K. pneumoniae) rats were treated with different dosages of astragaloside IV (5, 10, and 20 mg/kg) by intragastric administration. The levels of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α in bronchoalveolar lavage fluid (BALF) were determined. Pathological changes of lung tissue were inspected by HE staining. The expression of transforming growth factor (TGF)-β1 in lung tissue was determined with immunohistochemistry, and the expression levels of TGF-β1, p-Smad2/Smad2, p-Smad3/Smad3, IκBα/p-IκBα, and p65/p-p65 in lung tissue were determined by western blot. The mechanism was further investigated with TGF-β1 inhibitor SB-431542. Astragaloside IV reduced the elevated levels of pro-inflammatory cytokines caused by K. pneumoniae and improved lung tissue damage in a dose-dependent manner. Astragaloside IV also decreased the expression of TGF-β1/Smad signaling pathway-related proteins and decreased the protein levels of inflammation-related p-IκBα and p65 in lung tissues induced by K. pneumoniae. Additionally, it was found that the effects of 20 mg/kg astragaloside IV were similar to SB-431542, which could improve pulmonary fibrosis induced by K. pneumoniae, decrease the levels of TGF-β1/Smad signaling pathway-related proteins in lung, and reduce inflammation at the same time. Astragaloside IV could alleviate the inflammation of rat pneumonia induced by K. pneumoniae through suppressing the TGF-β1/Smad pathway.
first_indexed 2024-03-12T22:01:35Z
format Article
id doaj.art-e9726c2f76854efcb4eed08a8559843d
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-03-12T22:01:35Z
publishDate 2023-07-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-e9726c2f76854efcb4eed08a8559843d2023-07-25T07:43:02ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2023-07-015610.1590/1414-431x2023e12203Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathwayLei Lihttps://orcid.org/0009-0005-3231-1027Jie Guanhttps://orcid.org/0009-0005-7215-2737Rongjun Linhttps://orcid.org/0000-0002-1333-0223Fang Wanghttps://orcid.org/0009-0009-4519-1895Hui Mahttps://orcid.org/0009-0002-1211-1122Chenggang Maohttps://orcid.org/0009-0001-8403-9783Xingqing Guohttps://orcid.org/0000-0002-0333-0561Zhenghai Quhttps://orcid.org/0000-0002-4684-8651Renzheng Guanhttps://orcid.org/0000-0002-0196-8094Astragaloside IV is a biologically active substance derived from the traditional Chinese medicine Astragalus mambranaceus Bunge, and has antioxidant, anti-inflammatory, and anti-apoptotic properties. In this study, we aimed to investigate the effects of astragaloside IV on Klebsiella pneumonia rats and the underlying mechanisms. Klebsiella pneumoniae (K. pneumoniae) rats were treated with different dosages of astragaloside IV (5, 10, and 20 mg/kg) by intragastric administration. The levels of pro-inflammatory cytokines interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α in bronchoalveolar lavage fluid (BALF) were determined. Pathological changes of lung tissue were inspected by HE staining. The expression of transforming growth factor (TGF)-β1 in lung tissue was determined with immunohistochemistry, and the expression levels of TGF-β1, p-Smad2/Smad2, p-Smad3/Smad3, IκBα/p-IκBα, and p65/p-p65 in lung tissue were determined by western blot. The mechanism was further investigated with TGF-β1 inhibitor SB-431542. Astragaloside IV reduced the elevated levels of pro-inflammatory cytokines caused by K. pneumoniae and improved lung tissue damage in a dose-dependent manner. Astragaloside IV also decreased the expression of TGF-β1/Smad signaling pathway-related proteins and decreased the protein levels of inflammation-related p-IκBα and p65 in lung tissues induced by K. pneumoniae. Additionally, it was found that the effects of 20 mg/kg astragaloside IV were similar to SB-431542, which could improve pulmonary fibrosis induced by K. pneumoniae, decrease the levels of TGF-β1/Smad signaling pathway-related proteins in lung, and reduce inflammation at the same time. Astragaloside IV could alleviate the inflammation of rat pneumonia induced by K. pneumoniae through suppressing the TGF-β1/Smad pathway.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2023000100646&tlng=enLung inflammationTGF-β1/Smad pathwayAstragaloside IVK. pneumoniaePharmacology
spellingShingle Lei Li
Jie Guan
Rongjun Lin
Fang Wang
Hui Ma
Chenggang Mao
Xingqing Guo
Zhenghai Qu
Renzheng Guan
Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
Brazilian Journal of Medical and Biological Research
Lung inflammation
TGF-β1/Smad pathway
Astragaloside IV
K. pneumoniae
Pharmacology
title Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
title_full Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
title_fullStr Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
title_full_unstemmed Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
title_short Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway
title_sort astragaloside iv alleviates lung inflammation in klebsiella pneumonia rats by suppressing tgf β1 smad pathway
topic Lung inflammation
TGF-β1/Smad pathway
Astragaloside IV
K. pneumoniae
Pharmacology
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2023000100646&tlng=en
work_keys_str_mv AT leili astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT jieguan astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT rongjunlin astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT fangwang astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT huima astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT chenggangmao astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT xingqingguo astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT zhenghaiqu astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway
AT renzhengguan astragalosideivalleviateslunginflammationinklebsiellapneumoniaratsbysuppressingtgfb1smadpathway